Clinical Trial Update: Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating personalized pharmaconutrition therapy for myosteatosis and sarcopenia in gastric cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Myosteatosis
• Sarcopenia

Snippet

Sponsor: Biruni University | Conditions: Myosteatosis, Sarcopenia | Phase 2 | Status: COMPLETED